According to IMARC Group's latest research report, titled "๐€๐œ๐ญ๐ข๐ฏ๐ž ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐ˆ๐ง๐ ๐ซ๐ž๐๐ข๐ž๐ง๐ญ๐ฌ (๐€๐๐ˆ) ๐Œ๐š๐ซ๐ค๐ž๐ญ: ๐†๐ฅ๐จ๐›๐š๐ฅ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐“๐ซ๐ž๐ง๐๐ฌ, ๐’๐ก๐š๐ซ๐ž, ๐’๐ข๐ณ๐ž, ๐†๐ซ๐จ๐ฐ๐ญ๐ก, ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ, ๐š๐ง๐ ๐…๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘-๐Ÿ๐ŸŽ๐Ÿ๐Ÿ–," offers a comprehensive analysis of the industry, which comprises insights on the active pharmaceutical ingredients (API) market share. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global active pharmaceutical ingredients (API) market size reached ๐”๐’$ ๐Ÿ๐Ÿ๐Ÿ.๐Ÿ— ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ. Looking forward, IMARC Group expects the market to reach ๐”๐’$ ๐Ÿ‘๐ŸŽ๐Ÿ‘.๐Ÿ— ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ–, exhibiting a ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐ซ๐š๐ญ๐ž (๐‚๐€๐†๐‘) ๐จ๐Ÿ ๐Ÿ“.๐Ÿ”% during 2023-2028.

๐€๐œ๐ญ๐ข๐ฏ๐ž ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐ˆ๐ง๐ ๐ซ๐ž๐๐ข๐ž๐ง๐ญ๐ฌ (๐€๐๐ˆ) ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ:

Active pharmaceutical ingredients (API) are chemical compounds obtained from various sources, including plants, animals, and synthetic processes. They are synthetic active components of a finished pharmaceutical product (FPP) used to produce intended pharmacological outcomes. They are the substance in medications that are responsible for treating the illness or condition it is intended to treat. They are utilized in different medications, including prescription drugs, over-the-counter (OTC) medications, and dietary supplements.

๐†๐ž๐ญ ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐š๐ญ -https://www.imarcgroup.com/active-pharmaceutical-ingredients-market/requestsample

๐†๐ฅ๐จ๐›๐š๐ฅ ๐€๐œ๐ญ๐ข๐ฏ๐ž ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐ˆ๐ง๐ ๐ซ๐ž๐๐ข๐ž๐ง๐ญ๐ฌ (๐€๐๐ˆ) ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ž๐ฆ๐š๐ง๐ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ:

The increasing prevalence of chronic diseases, cancer, arthritis, and respiratory disorders and the rising aging population, which is more prone to develop these medical conditions, represents one of the key factors driving the demand for APIs around the world. Moreover, the growing need for generic drugs on account of expanding healthcare costs is catalyzing the demand for APIs to improve the effectiveness of drugs. In addition, the increasing preference for personalized medicines and rising demand for biologic drugs that are made using living cells is favoring the market growth. Apart from this, regulatory authorities of numerous countries are implementing strict regulations to ensure the safety and quality of excipients used in the production of medicinal products. Furthermore, extensive research and development (R&D) activities in the pharmaceutical industry by key players to develop next-generation medicines and therapies are influencing the market positively.

๐ƒ๐จ ๐ฒ๐จ๐ฎ ๐ค๐ง๐จ๐ฐ ๐ฆ๐จ๐ซ๐ž ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง, ๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐ญ๐จ ๐จ๐ฎ๐ซ ๐š๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ ๐š๐ญ- https://www.imarcgroup.com/active-pharmaceutical-ingredients-market

๐“๐จ๐ฉ ๐€๐œ๐ญ๐ข๐ฏ๐ž ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐ˆ๐ง๐ ๐ซ๐ž๐๐ข๐ž๐ง๐ญ๐ฌ ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ ๐–๐จ๐ซ๐ฅ๐๐ฐ๐ข๐๐ž:

  • Pfizer Inc.
  • Novartis International AG
  • Sanofi SA
  • Boehringer Ingelheim Group
  • Bristol-Myers Squibb Company
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Merck & Co. Inc.
  • AbbVie Inc.

๐Š๐ž๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐›๐ฒ ๐ƒ๐ซ๐ฎ๐  ๐“๐ฒ๐ฉ๐ž:

  • Innovative Active Pharmaceutical Ingredients (API)
  • Generic Active Pharmaceutical Ingredients (API)

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐›๐ฒ ๐Œ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ž๐ซ:

  • Captive Manufacturers
  • Merchant API Manufacturers
  • Innovative Merchant API Manufacturers
  • Generic Merchant API Manufacturers

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐›๐ฒ ๐’๐ฒ๐ง๐ญ๐ก๐ž๐ฌ๐ข๐ฌ:

(๐Ÿ). ๐’๐ฒ๐ง๐ญ๐ก๐ž๐ญ๐ข๐œ ๐€๐œ๐ญ๐ข๐ฏ๐ž ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐ˆ๐ง๐ ๐ซ๐ž๐๐ข๐ž๐ง๐ญ๐ฌ (๐€๐๐ˆ):

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐›๐ฒ ๐“๐ฒ๐ฉ๐ž:

  • Innovative Synthetic APIs
  • Generic Synthetic APIs

(๐Ÿ). ๐๐ข๐จ๐ญ๐ž๐œ๐ก ๐€๐œ๐ญ๐ข๐ฏ๐ž ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐ˆ๐ง๐ ๐ซ๐ž๐๐ข๐ž๐ง๐ญ๐ฌ (๐€๐๐ˆ):

(๐š). ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐›๐ฒ ๐“๐ฒ๐ฉ๐ž:

  • Innovative Biotech APIs
  • Biosimilars

(๐›). ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ:

  • Monoclonal Antibodies
  • Vaccines
  • Cytokines
  • Fusion Proteins
  • Therapeutic Enzymes
  • Blood Factors

(๐œ). ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐๐ฒ ๐„๐ฑ๐ฉ๐ซ๐ž๐ฌ๐ฌ๐ข๐จ๐ง ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ:

  • Mammalian Expression Systems
  • Microbial Expression Systems
  • Yeast Expression Systems
  • Transgenic Animal Systems
  • Others

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐›๐ฒ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง:

  • Oncology
  • Cardiovascular and Respiratory
  • Diabetes
  • Central Nervous System Disorders
  • Neurological Disorders
  • Others

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐›๐ฒ ๐‘๐ž๐ ๐ข๐จ๐ง:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

๐–๐ก๐จ ๐ฐ๐ž ๐š๐ซ๐ž:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐ฎ๐ฌ:
๐ˆ๐Œ๐€๐‘๐‚ ๐†๐ซ๐จ๐ฎ๐ฉ
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800